








The BB-12® strain is tested in numerous clinical trials from newborn preterm infants to elderly in doses up to 100 billion CFU/day with no reported side effects.
BB-12® is furthermore GRAS (Generally Recognized As Safe) notified by FDA and approved by the Danish Medicines Agency as a Natural Health Product.
Human studies have shown that BB-12® alone or in combinations has a beneficial effect within gastrointestinal health and immune health.
Studies indicate that BB-12®:
You will find abstracts of all the studies supporting these effects of BB-12® in our Selected Summaries.
Studies furthermore indicate that BB-12® has an impact on colic and reduces risk of rotavirus diarrhea in infants. Studies are also published on its immune modulating effect.
All of the effects of the BB-12® strain makes it an excellent choice for a range of health areas, which you will also see from Chr. Hansen's probiotic product offerings handout (PDF, 461 KB).
Please contact our Sales Directors to learn more about your possibilities of using BB-12® in your probiotic product.


A number of our customers have products formulated with BB-12®. Read more about the Vidazorb success with Chr. Hansen's probiotics, the Sagitus success with their Liveo product, or the successfull USANA probiotic food supplement product all containing BB-12®.